肠-骨-炎症轴:肠道屏障破坏作为骨质疏松的核心驱动因素
本综述总结肠道屏障破坏在骨质疏松中的作用,聚焦肠道屏障完整性、菌群失调、炎症介质、免疫激活与骨代谢。肠道屏障破坏增加通透性,促进微生物产物和促炎介质入血,引发慢性低度炎症,增强破骨细胞分化与活性、抑制成骨细胞功能,破坏骨重建平衡。保护肠道屏障完整性和调节肠道菌群可能成为骨质疏松防治策略。
要点
- 肠道屏障破坏增加肠道通透性,促进微生物产物和促炎介质进入体循环。
- 慢性低度炎症增强破骨细胞分化与活性、抑制成骨细胞功能,破坏骨重建平衡。
- 保护肠道屏障完整性和调节肠道菌群可能为骨质疏松提供防治新策略。
核心结论
- 肠道屏障功能障碍通过调节全身炎症和骨代谢在骨质疏松中发挥关键作用。
- 保护肠道屏障完整性和调节肠道菌群可能为骨质疏松管理提供有前景的预防和治疗途径。
研究设计与样本
- 本综述综合现有文献中的相关实验和临床研究,聚焦肠道屏障完整性、肠道菌群失调、炎症介质、免疫激活和骨代谢。
主要发现
- 肠道屏障破坏增加肠道通透性,促进微生物产物和促炎介质转位进入全身循环。
- 该过程促进慢性低度炎症,增强破骨细胞分化和活性,抑制成骨细胞功能,并破坏骨重建平衡。
- 肠道菌群失衡、免疫激活和持续炎症信号共同导致骨质疏松中的骨丢失和结构恶化。
临床怎么用
- 临床可关注保护肠道屏障完整性和调节肠道菌群作为骨质疏松的潜在预防和治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoporosis is a systemic skeletal disorder traditionally attributed to imbalances in bone metabolism. Increasing evidence suggests that the intestinal environment and chronic inflammation play important roles in itspathogenesis. The gut-bone-inflammation axis provides a novel perspective for understanding the interactions among intestinal barrier function, immune regulation, and bone homeostasis. This review aims to summarize current evidence regarding the role of intestinal barrier disruption in osteoporosis and to discuss its contribution within the framework of the gut-bone-inflammation axis. Relevant experimental and clinical studies from the existing literature were reviewed and synthesized, with a focus on intestinal barrier integrity, gut microbiota dysbiosis, inflammatory mediators, immune activation, and bone metabolism. Disruption of the intestinal barrier increases intestinal permeability, facilitating the translocation of microbial products and pro-inflammatory mediators into the systemic circulation. This process promotes chronic low-grade inflammation, enhances osteoclast differentiation and activity, suppresses osteoblast function, and disrupts the balance of bone remodeling. Gut microbiota imbalance, immune activation, and sustained inflammatory signaling collectively contribute to bone loss and structural deterioration in osteoporosis. Intestinal barrier dysfunction plays a pivotal role in osteoporosis through modulation of systemic inflammation and bone metabolism. Strategies aimed at preserving intestinal barrier integrity and regulating the gut microbiota may offer promising preventive and therapeutic approaches for the management of osteoporosis.
引用
- Liu X, Hu K, Zhu T, et al. The gut-bone-inflammation axis: intestinal barrier disruption as a central driver of osteoporosis. Osteoporos Int. 2026. PMID: 42234035. doi:10.1007/s00198-026-07855-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。